ResearcherInstituto de Biomedicina de SevillaActive in the last 2 years
Francisco Javier Padillo Ruiz
Matched on ORCID iD 0000-0002-1220-0822; OpenAlex author ID A5091354337. Sources: ClinicalTrials.gov.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 trial · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 7
- CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models. Co-author DOI 10.1007/s13346-025-02013-5↗
- Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mobilization of circulating tumour cells an… Co-author DOI 10.1093/bjsopen/zrae123↗
- TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Release in Pancreatic Cancer. Last author DOI 10.3390/bioengineering10020183↗
- Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm. Last author DOI 10.3390/ijms24054278↗
- Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients. Co-author DOI 10.3390/cancers13246153↗
- Translational pancreatic cancer research: A comparative study on patient-derived xenograft models. Last author DOI 10.3748/wjg.v24.i7.794↗
- Improvement of capecitabine antitumoral activity by melatonin in pancreatic cancer. Last author DOI 10.1097/mpa.0b013e318201ca4f↗
Trials 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carmen Cepeda Franco · 5 shared papers, 2021–2025 · strength 0.83
- Paper CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic c… DOI 10.1007/s13346-025-02013-5↗
- Paper TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Re… DOI 10.3390/bioengineering10020183↗
- Paper Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm. DOI 10.3390/ijms24054278↗
- Francisco José Calero-Castro · 3 shared papers, 2021–2023 · strength 0.45
- Paper TARTESSUS: A Customized Electrospun Drug Delivery System Loaded with Irinotecan for Local and Sustained Chemotherapy Re… DOI 10.3390/bioengineering10020183↗
- Paper Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm. DOI 10.3390/ijms24054278↗
- Paper Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients. DOI 10.3390/cancers13246153↗
- María José Serrano · 2 shared papers, 2021–2023 · strength 0.27
- Paper Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm. DOI 10.3390/ijms24054278↗
- Paper Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients. DOI 10.3390/cancers13246153↗
- J.M. Álamo-Martínez · 2 shared papers, 2021–2024 · strength 0.25
- Paper Effects of the superior mesenteric artery approach versus the no-touch approach during pancreatoduodenectomy on the mob… DOI 10.1093/bjsopen/zrae123↗
- Paper Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients. DOI 10.3390/cancers13246153↗
- Anna Huguet Ninou · 1 shared paper, 2025 · strength 0.23
- María Virtudes Céspedes · 1 shared paper, 2025 · strength 0.23
- Oihane Mitxelena‐Iribarren · 1 shared paper, 2023 · strength 0.18
- Fabio Ausania · 1 shared paper, 2024 · strength 0.15
- Luis Muñoz‐Bellvís · 1 shared paper, 2024 · strength 0.15
- Esteban Cugat Andorrà · 1 shared paper, 2024 · strength 0.15
- Gerardo Blanco‐Fernández · 1 shared paper, 2024 · strength 0.15
- Luis Sabater · 1 shared paper, 2024 · strength 0.15
- Mercedes Rubio-Manzanares Dorado · 1 shared paper, 2018 · strength 0.08
- Juan Francisco Ruiz-Rabelo · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.